EFFECT OF D-AMPHETAMINE AND L-AMPHETAMINE ON RAT PLASMA PROLACTIN LEVELS

被引:20
作者
MELTZER, HY
FESSLER, RG
SIMONOVIC, M
DOHERTY, J
FANG, VS
机构
[1] UNIV CHICAGO, PRITZKER SCH MED, DEPT PHARMACOL & PHYSIOL SCI, CHICAGO, IL 60637 USA
[2] UNIV CHICAGO, PRITZKER SCH MED, DEPT MED, CHICAGO, IL 60637 USA
[3] ILLINOIS STATE PSYCHIAT INST, CHICAGO, IL 60612 USA
关键词
5-Hydroxytryptophan; Alpha-methylparatyrosine; d-Amphetamine; Dopamine; l-Amphetamine; Prolactin; Reserpine; Supersensitivity; Tolerance;
D O I
10.1007/BF00426812
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Although d- and l-amphetamine had no effect on plasma prolactin levels in untreated male rats, both d- and l-amphetamine reversed the increase in plasma prolactin levels produced by reserpine and 5-hydroxytryptophan (5-HTP). Only d-amphetamine significantly reversed the effect of alpha-methylparatyrosine (AMPT) on plasma prolactin levels. This reversal is probably due to a direct or indirect dopamine agonist effect of amphetamine, rather than to an effect on norepinephrine. This conclusion is based on the finding that apomorphine, a direct-acting dopamine agonist, reversed the reserpine-induced increase in prolactin secretion, while clonidine, a direct-acting alpha-adrenergic agonist, potentiated the reserpine-induced stimulation of prolactin secretion. The effect of d-amphetamine on the increase in plasma prolactin levels produced by reserpine, 5-HTP, or AMPT was always greater than that of the l-isomer, suggesting that the d-isomer has a more profound effect on dopaminerelease or neuronal reuptake, or both, than l-amphetamine. Chronic administration of d-amphetamine prior to reserpine did not inhibit the ability of d-amphetamine to reverse the reserpine-induced increase in plasma prolactin. Chronic administration of AMPT did not enhance the ability of d-amphetamine to reverse the AMPT-induced increase in plasma prolactin. © 1979 Springer-Verlag.
引用
收藏
页码:63 / 69
页数:7
相关论文
共 53 条
[51]  
STOLK JM, 1967, J PHARMACOL EXP THER, V158, P140
[52]  
THORNBURG JE, 1973, RES COMMUN CHEM PATH, V5, P81
[53]  
WEISSMAN A, 1966, J PHARMACOL EXP THER, V151, P339